Vitality Watch

Dossier clinicaltrials trial early 11-sep-2026
Small or early-phase human trial or pilot study

The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression

Key claim: A short clinical study is testing whether lumateperone changes mood, inflammation, obesity, and physiologic aging—including MRI-estimated brain biological age—in adults with bipolar depression.

Abstract

This research study examines how a medication called lumateperone may affect mood symptoms, and inflammation in adults with bipolar disorder over approximately 6 weeks. An MRI scan to calculate biological age of the brain will also be obtained at the start of the study.

Why this matters

A short clinical study is testing whether lumateperone changes mood, inflammation, obesity, and physiologic aging—including MRI-estimated brain biological age—in adults with bipolar depression.

Source

Link

Briefing card

The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
Stage: trial early · clinicaltrials · 11-sep-2026

A short clinical study is testing whether lumateperone changes mood, inflammation, obesity, and physiologic aging—including MRI-estimated brain biological age—in adults with bipolar depression.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07699445

build build 880 · 2bcef25 · 2026-11-18